Hip FractureNCT07639762
Comparison of the Efficacy of Ultrasound-guided Supra-inguinal Fascia Iliaca and Lumbar Erector Spina Plan Block in Hip Fractures
An observational study of Hip Fracture and Pain Management, run by Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital at 1 site in Turkey (Türkiye).
Trial summary
The aim of our study was to evaluate the efficacy and patient satisfaction level of SI-FIB and lumbar ESPB for positioning and postoperative analgesia during spinal anesthesia in patients undergoing hip fracture surgery. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Hip Fracture, Pain Management, Multimodal Analgesia
- How many people
- 100 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 16 May 2025to 31 Jan 2026
- How long will I take part?
- 1 Month
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients who underwent surgery with spinal anesthesia due to hip fracture at Sancaktepe Şehit Prof. Dr. İlhan Varank Education and Research Hospital of Health Sciences University and were treated with suprainguinal plane block and lumbar rectus fascia plane block for postoperative analgesia will be examined in the study.
Who may be able to join
- 18 years of age or older
- American Society of Anesthesiologists (ASA) I-III risk class,
- Patients and/or guardians informed and given informed consent regarding the study
Who cannot join
- Central-autonomic nervous system or neuropsychiatric disorders,
- Opioid use,
- Contraindications for the planned block,
- Known allergies to the medications to be administered,
- Patients who refuse to participate in the study
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Şehit Prof. Dr. İlhan Varank Sancaktepe Training and Research Hospital
Istanbul, Sancaktepe, 34785
About this study
Official title: Kalça kırıklarında Ultrason rehberliğinde yapılan Supra-inguinal Fasya Iliaca ve Lomber Erektor Spina Plan bloğunun Etkinliklerinin karşılaştırılması
The aim of our study was to evaluate the efficacy and patient satisfaction level of SI-FIB and lumbar ESPB for positioning and postoperative analgesia during spinal anesthesia in patients undergoing hip fracture surgery.
Read the detailed description
Hip fractures, which are one of the leading causes of mortality and morbidity with increasing age, are common and usually require surgery and cause severe pain in the perioperative period, which may result in delirium, sleep disturbances and chronic pain. This pain can be managed using neuraxial and regional techniques, as well as pharmacologic agents such as nonsteroidal analgesics, opioids and gabapentinoids, and interventions such as periarticular injections and peripheral nerve blocks. Supra-inguinal fascia iliaca block (SI-FIB) is a technique that blocks all components of the lumbar plexus, including the femoral nerve, latero-femoral nerve and obturator nerve. It is thought to function in a similar way to the anterior lumbar plexus block. Studies have successfully demonstrated the effectiveness of SIFIB in reducing postoperative pain after hip surgery. The lumbar erector spina plan block (ESPB) has been described for use in hip and femur surgery and radiologic evaluation and clinical results have shown that it provides similar analgesia to the lumbar plexus block at high volumes. It is accepted that multimodal analgesia is the best option for pain control and peripheral nerve blocks are effectively applied for this purpose. In this way, opioid use and related side effects such as nausea, vomiting, pruritus and sedation are reduced, and early mobilization, reduced hospital stay and prevention of postoperative complications are also contributed.
- Conditions
- Hip Fracture, Pain Management, Multimodal Analgesia, Peripheral Nerve Block, Lumbar Erector Spinae Plane Block, Suprainguinal Fasia Iliaca Block
- Keywords
- Hip fracture, pain management, multimodal analgesia, suprainguinal fasia iliaca block, lumbar erector spinae plane block
- Medical subject headings
- Hip Fractures, Agnosia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Grup-S | Patients were divided into 2 groups and grouped as Group-S with suprainguinal fascia iliaca block, Group-L with lumbar erector spina plan block group. For postoperative analgesia, preoperative midazolam premedication and USG-guided suprainguinal fascia iliaca plan block with 30 ml of 0.25% Bupivacaine was planned to be performed in Group-S and lumbar erector spina plan block was planned to be performed at the L3-4 level in Group-L. | |
| Grup-L | Patients were divided into 2 groups and grouped as Group-S with suprainguinal fascia iliaca block, Group-L with lumbar erector spina plan block group. For postoperative analgesia, preoperative midazolam premedication and USG-guided suprainguinal fascia iliaca plan block with 30 ml of 0.25% Bupivacaine was planned to be performed in Group-S and lumbar erector spina plan block was planned to be performed at the L3-4 level in Group-L. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Assessment of pain during spinal anesthesia position
The primary objective of our study is to compare the effectiveness of SI-FIB and lumbar ESPB in patients undergoing hip fracture surgery by evaluating NRS scores during positioning for spinal anesthesia.
Measured: The NRS score will be recorded before the block. The NRS score will be recorded 20 minutes after the block is administered. The NRS score will be recorded when the patient is placed in a sitting position for spinal anesthesia.
Secondary outcomes (3)
Postoperative Pain Intensity at Rest and During Activity
Postoperative pain intensity at rest and during activity will be assessed using the Numeric Rating Scale. The Numeric Rating Scale ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate worse pain.
Unit of Measure: Numeric Rating Scale score
Measured: 0, 2, 6, 12, and 24 hours postoperatively
Additional Analgesic Consumption
Additional analgesic consumption will be recorded as the total amount of analgesic administered postoperatively.
Measured: From the end of surgery to 24 hours postoperatively
Patient Satisfaction With Postoperative Analgesia
Postoperative quality of recovery will be assessed using the 15-item Quality of Recovery questionnaire (QoR-15). The total score ranges from 0 to 150, with higher scores indicating better postoperative recovery.
Measured: 24 hours postoperatively
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Jun 2026
- Study start16 May 2025
- Primary completion31 Jan 2026
- Study completion31 Jan 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for Hip FractureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 100 participants (actual)
- Target duration
- 1 Month
Sponsor and investigators
- Lead sponsor
- Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07639762
- Sponsor's protocol ID
- Ivstrh
- Status last verified
- Sep 2026
- First submitted
- 19 Jan 2026
- Last updated
- 16 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: I do not plan to share IPD for data security reasons.
Publications
Hebbard P, Ivanusic J, Sha S. Ultrasound-guided supra-inguinal fascia iliaca block: a cadaveric evaluation of a novel approach. Anaesthesia. 2011 Apr;66(4):300-5. doi: 10.1111/j.1365-2044.2011.06628.x. Epub 2011 Feb 24.
PubMed 21401544Desmet M, Vermeylen K, Van Herreweghe I, Carlier L, Soetens F, Lambrecht S, Croes K, Pottel H, Van de Velde M. A Longitudinal Supra-Inguinal Fascia Iliaca Compartment Block Reduces Morphine Consumption After Total Hip Arthroplasty. Reg Anesth Pain Med. 2017 May/Jun;42(3):327-333. doi: 10.1097/AAP.0000000000000543.
PubMed 28059869Eastburn E, Hernandez MA, Boretsky K. Technical success of the ultrasound-guided supra-inguinal fascia iliaca compartment block in older children and adolescents for hip arthroscopy. Paediatr Anaesth. 2017 Nov;27(11):1120-1124. doi: 10.1111/pan.13227.
PubMed 29030933Alves WM Jr, Migon EZ, Zabeu JL. PAIN FOLLOWING TOTAL KNEE ARTHROPLASTY - A SYSTEMATIC APPROACH. Rev Bras Ortop. 2015 Dec 12;45(5):384-91. doi: 10.1016/S2255-4971(15)30424-9. eCollection 2010 Sep-Oct.
PubMed 27022583
Study at a glance
From the registry record, last updated by the sponsor on 16 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Kalça kırıklarında Ultrason rehberliğinde yapılan Supra-inguinal Fasya Iliaca ve Lomber Erektor Spina Plan bloğunun Etkinliklerinin karşılaştırılması
- ClinicalTrials.gov ID
- NCT07639762
- Acronym / sponsor ID
- Ivstrh
- Conditions
- Hip Fracture, Pain Management, Multimodal Analgesia, Peripheral Nerve Block, Lumbar Erector Spinae Plane Block, Suprainguinal Fasia Iliaca Block
- Keywords
- Hip fracture, pain management, multimodal analgesia, suprainguinal fasia iliaca block, lumbar erector spinae plane block
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 100 participants (actual)
- Lead sponsor
- Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research HospitalUniversity, hospital or other
- Study start
- 16 May 2025 (actual)
- Primary completion
- 31 Jan 2026 (actual)
- Study completion
- 31 Jan 2026 (actual)
- First posted
- 10 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of our study was to evaluate the efficacy and patient satisfaction level of SI-FIB and lumbar ESPB for positioning and postoperative analgesia during spinal anesthesia in patients undergoing hip fracture surgery.
Detailed description
Hip fractures, which are one of the leading causes of mortality and morbidity with increasing age, are common and usually require surgery and cause severe pain in the perioperative period, which may result in delirium, sleep disturbances and chronic pain. This pain can be managed using neuraxial and regional techniques, as well as pharmacologic agents such as nonsteroidal analgesics, opioids and gabapentinoids, and interventions such as periarticular injections and peripheral nerve blocks. Supra-inguinal fascia iliaca block (SI-FIB) is a technique that blocks all components of the lumbar plexus, including the femoral nerve, latero-femoral nerve and obturator nerve. It is thought to function in a similar way to the anterior lumbar plexus block. Studies have successfully demonstrated the effectiveness of SIFIB in reducing postoperative pain after hip surgery. The lumbar erector spina plan block (ESPB) has been described for use in hip and femur surgery and radiologic evaluation and clinical results have shown that it provides similar analgesia to the lumbar plexus block at high volumes. It is accepted that multimodal analgesia is the best option for pain control and peripheral nerve blocks are effectively applied for this purpose. In this way, opioid use and related side effects such as nausea, vomiting, pruritus and sedation are reduced, and early mobilization, reduced hospital stay and prevention of postoperative complications are also contributed.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 1 Month
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Grup-S | – | –Patients were divided into 2 groups and grouped as Group-S with suprainguinal fascia iliaca block, Group-L with lumbar erector spina plan block group. For postoperative analgesia, preoperative midazolam premedication and USG-guided suprainguinal fascia iliaca plan block with 30 ml of 0.25% Bupivacaine was planned to be performed in Group-S and lumbar erector spina plan block was planned to be performed at the L3-4 level in Group-L. |
| Grup-L | – | –Patients were divided into 2 groups and grouped as Group-S with suprainguinal fascia iliaca block, Group-L with lumbar erector spina plan block group. For postoperative analgesia, preoperative midazolam premedication and USG-guided suprainguinal fascia iliaca plan block with 30 ml of 0.25% Bupivacaine was planned to be performed in Group-S and lumbar erector spina plan block was planned to be performed at the L3-4 level in Group-L. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients who underwent surgery with spinal anesthesia due to hip fracture at Sancaktepe Şehit Prof. Dr. İlhan Varank Education and Research Hospital of Health Sciences University and were treated with suprainguinal plane block and lumbar rectus fascia plane block for postoperative analgesia will be examined in the study.
Key inclusion criteria (3 listed)
- 18 years of age or older
- American Society of Anesthesiologists (ASA) I-III risk class,
- Patients and/or guardians informed and given informed consent regarding the study
Key exclusion criteria (5 listed)
- Central-autonomic nervous system or neuropsychiatric disorders,
- Opioid use,
- Contraindications for the planned block,
- Known allergies to the medications to be administered,
- Patients who refuse to participate in the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Assessment of pain during spinal anesthesia position
Time frame: The NRS score will be recorded before the block. The NRS score will be recorded 20 minutes after the block is administered. The NRS score will be recorded when the patient is placed in a sitting position for spinal anesthesia.
The primary objective of our study is to compare the effectiveness of SI-FIB and lumbar ESPB in patients undergoing hip fracture surgery by evaluating NRS scores during positioning for spinal anesthesia.
3 secondary outcomes
Postoperative Pain Intensity at Rest and During Activity
Time frame: 0, 2, 6, 12, and 24 hours postoperatively
Additional Analgesic Consumption
Time frame: From the end of surgery to 24 hours postoperatively
Patient Satisfaction With Postoperative Analgesia
Time frame: 24 hours postoperatively
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Sep 2026.
- Background: PubMed 21401544Hebbard P, Ivanusic J, Sha S. Ultrasound-guided supra-inguinal fascia iliaca block: a cadaveric evaluation of a novel approach. Anaesthesia. 2011 Apr;66(4):300-5. doi: 10.1111/j.1365-2044.2011.06628.x. Epub 2011 Feb 24.
- Background: PubMed 28059869Desmet M, Vermeylen K, Van Herreweghe I, Carlier L, Soetens F, Lambrecht S, Croes K, Pottel H, Van de Velde M. A Longitudinal Supra-Inguinal Fascia Iliaca Compartment Block Reduces Morphine Consumption After Total Hip Arthroplasty. Reg Anesth Pain Med. 2017 May/Jun;42(3):327-333. doi: 10.1097/AAP.0000000000000543.
- Background: PubMed 29030933Eastburn E, Hernandez MA, Boretsky K. Technical success of the ultrasound-guided supra-inguinal fascia iliaca compartment block in older children and adolescents for hip arthroscopy. Paediatr Anaesth. 2017 Nov;27(11):1120-1124. doi: 10.1111/pan.13227.
- Background: PubMed 27022583Alves WM Jr, Migon EZ, Zabeu JL. PAIN FOLLOWING TOTAL KNEE ARTHROPLASTY - A SYSTEMATIC APPROACH. Rev Bras Ortop. 2015 Dec 12;45(5):384-91. doi: 10.1016/S2255-4971(15)30424-9. eCollection 2010 Sep-Oct.
- Related InfoLink provided by the sponsor.
- Individual participant dataSharing planned: No. I do not plan to share IPD for data security reasons.
Related trials for Hip Fracture
Not yet recruitingPhase 4
Effect of Ondansetron on the Incidence of Spinal Anaesthesia-Induced Hypotension in Elderly Patients Undergoing Fracture Hip Surgery
Spinal Anaesthesia Induced Hypotension
Not yet recruiting
Lumbar Erector Spinae Plane Block Versus PENG Block for Hip Fracture Surgery
Femur Neck Fracture, Hip Fractures
Active, not recruiting
Lumbar-Sacral Plexus Block vs Fascia Iliaca Block Plus Low-Dose Spinal Anesthesia for Femoral Neck Fracture Surgery
Femoral Neck Fractures, Nerve Block
RecruitingObservational study
Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures
Fracture; Pelvic, Insufficiency Fractures
Not yet recruiting
A Decision Support Tool for Common Surgical Fixations of Hip Fractures
Hip Fracture Surgeries, High Risk Population of Hip Fractures
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hip Fracture and Pain Management, run by Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Assessment of pain during spinal anesthesia position (time frame: The NRS score will be recorded before the block. The NRS score will be recorded 20 minutes after the block is administered. The NRS score will be recorded when the patient is placed in a sitting position for spinal anesthesia.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07639762, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2026.